Bioethics: performance enhancement

Claim: Students without a medical diagnosis should not be permitted to use prescription stimulants such as amphetamine drugs to boost their performance on exams.\nEvidence: Prescription stimulants raise the level of dopamine and norepinephrine in the brain, which can increase short-term alertness and focus. In people without a condition like ADHD, though, they also carry documented risks including raised heart rate and blood pressure, disrupted sleep, anxiety, and the potential for dependence. On top of the health risks, if some students take a pill to stay sharp during a high-stakes test, other students feel pressure to do the same just to keep their scores competitive.\nReasoning: Allowing non-medical stimulant use creates a coercion problem that looks a lot like other enhancement debates: students who would rather not take a drug are pushed to risk their health so they are not left behind. Because these stimulants cause real physical and psychological harm in people who do not need them, and because they turn a test of preparation into a test of who is willing to medicate, restricting non-medical use protects both student health and the fairness of the assessment. That combined harm outweighs an individual student's claim to use whatever they want to get an edge.\nCounter-argument I heard and my response: A classmate argued that students are old enough to make their own choices about their own bodies. I agree that personal autonomy matters, but in a shared, graded setting one student's choice raises the bar for everyone else and forces a health risk onto peers who never wanted it. Because the harm spills over onto others and the drug carries real dangers, the fairness and safety concerns justify the restriction.